Psyence Biomedical Ltd.
- PBM
- NASDAQ
- Biotechnology
- Psilocybin Therapy
- Psychedelic Medicine
$4.22
Today −3.79%Quote Oct 19, 2026, 02:32 PM UTC
−33.23%over the last month
Max drawdown −37.7%From 1-month high −36.3%3 months +33.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.7M
Quote Oct 19
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$3.97
6.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PBMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
12